GHIT Fund [to 7 November 2015]
https://www.ghitfund.org/
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical companies, the Japanese Government and the Bill & Melinda Gates Foundation.

.
Press Room 2015.11.05
From a Phase 2 TB Vaccine Trial, to Early Work to Neutralize Drug-Resistant Malaria, $10.7 Million in New Investments from GHIT Fund Escalates and Diversifies Japan’s Global Health Commitments
Projects advance product development partnerships with Japanese pharma, Kickstart GHIT’s Grand Challenges; New funds also target dengue, leishmaniasis

The Global Health Innovative Technology Fund (GHIT Fund), which in the last two years has invested US$43 million to develop innovative tools for fighting diseases worldwide, today announced it is investing $10.7 million* at multiple points in the product development pipeline to seek new interventions for malaria, tuberculosis (TB), leishmaniasis and dengue.